Pages

▼
Wednesday, February 18, 2026

Medicare Part D Pharmacy Networks in 2026: Supermarkets Dominate as Drugstores Stall and Independents Walk Away

›
The Centers for Medicare & Medicaid Services (CMS) has just released its initial 2026 data on enrollment in Medicare Part D prescription...
Friday, February 13, 2026

The Key to a Better Patient Experience: Improved GTN

›
Today’s guest post comes from Gerard Rivera, CEO and Co-Founder of RIS Rx. Gerard reframes patient affordability as a clinical issue rath...
Tuesday, February 10, 2026

Copay Accumulators and Maximizers in 2025: Popular, Profitable, and Problematic

›
Valentine’s Day is almost here! It’s the perfect time for our annual update on plan sponsors’ enduring sweetheart: copay accumulators and ma...
Friday, February 06, 2026

In an Uncertain 340B Environment, Kalderos Offers a Clear Path Forward

›
Today’s guest post comes from Angie Franks, Chief Executive Officer at Kalderos. Angie examines the growing uncertainty surrounding the 3...
Wednesday, February 04, 2026

The FTC Blows Up Express Scripts’ PBM Model—and Launches the Net Pricing Drug Channel

›
Earlier today, the Federal Trade Commission (FTC) announced an extraordinary settlement with Express Scripts that fundamentally reshapes its...
Tuesday, February 03, 2026

Latest CMS Data Reveal Six Trends Reshaping U.S. Drug Spending

›
The boffins at the Centers for Medicare & Medicaid Services (CMS) recently dropped the latest National Health Expenditure (NHE) data, wh...
Friday, January 30, 2026

From Cost Center to Insights Center: How Patient Support Will Go Beyond the Call in 2026

›
Today’s guest post comes from Brok Vandersteen, Vice President of Business Development at AssistRx. Brok argues that in 2026, traditional...
Tuesday, January 27, 2026

Drug Channels News Roundup, January 2026: Cuban vs. Optum, McKesson’s Biosimilar Play, States vs. Accumulators, 340B Windfalls, and Ozempic Ads

›
Super Bowl LX is almost here! Time for some blowout beer and snack commercials, occasionally interrupted by an actual football game. DCI’s h...
Friday, January 23, 2026

New Drug Launches in a Self-Pay World: Why Access Strategy Matters as Much as Innovation

›
Today’s guest post comes from Laura Jensen, Chief Commercial Officer and President, Pharma Solutions at GoodRx. Laura argues that patient...
Thursday, January 22, 2026

The Big Three PBMs’ 2026 Formulary Exclusions: MFP, Private Label Biosimilars, and Direct-to-Patient Threats for PBMs

›
For 2026, the three largest pharmacy benefit managers (PBMs)—Caremark (CVS Health), Express Scripts (Cigna), and Optum Rx (United Health Gro...
Wednesday, January 14, 2026

The Net Pricing Revolution in the Drug Channel: What’s Deflating the Gross-to-Net Bubble

›
As I highlighted last week , we are entering the Net Pricing Drug Channel (NPDC) era—a market environment in which net prices, not list pri...
Tuesday, January 13, 2026

NEW: The Drug Channels 2026 Video Webinar Series

›
Join Dr. Adam J. Fein, president of Drug Channels Institute (DCI), for three new video webinars during 2026. These live, interactive events ...